Dynamics of Pseudomonas aeruginosa During Bacteremia

菌血症期间铜绿假单胞菌的动态

基本信息

  • 批准号:
    10222524
  • 负责人:
  • 金额:
    $ 19.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-24 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Pseudomonas aeruginosa (PA) is the third most common gram-negative etiology of bloodstream infections, and these infections are associated with a crude mortality rate of 39%. Despite their frequency and severity, PA bloodstream infections are relatively poorly understood compared to pneumonia, burn infections, and keratitis. To investigate the pathogenesis of PA bloodstream infections, we have used a mouse model in which the tail vein is injected with a library of barcoded bacteria. Our preliminary experiments yielded several unexpected findings. First, in approximately half of severely ill bacteremic mice, the PA bacteria found disseminated throughout the body were descendants of just a few bacterial cells, suggesting that only a small number of the PA in the initial inoculum persisted and disseminated to cause severe disease. Second, PA bacteria in the blood migrated through a tight bottleneck to the gallbladder, which was a protective niche that allowed for a small number of PA to replicate to extremely high numbers. From there, these descendants of just a few PA bacteria seeded the intestines, presumably by passing through the common bile duct. This finding is particularly interesting in the context of other reports suggesting that PA is capable of migrating from the intestines to the bloodstream. Together, these observations suggest the intriguing hypothesis that spread of PA from the bloodstream to the intestines and back to the bloodstream may generate a "positive feedback loop" in which the gallbladder serves as an amplifier of PA numbers. In this application, we propose to address this limitation and directly test our hypothesis by performing the following specific aims: (1) Characterize bacterial dynamics over the course of PA bloodstream infections. (2) Determine whether interventions that disrupt PA transit through the intestines improve outcomes in bloodstream infections. Completion of these aims has the potential to uncover novel pathogenic mechanisms that contribute to the poor outcomes observed in PA bloodstream infections. The impact of these studies is three-fold: (i) they may provide a rationale for examining the pathogenesis of bloodstream infections caused by bacteria other than PA; (ii) the knowledge gained may be used as a foundation and justification for costlier and more laborious studies in humans with PA bloodstream infections; and (iii) these studies may inform novel therapeutic interventions that lower the unacceptably high mortality rates currently associated with PA bacteremia.
铜绿假单胞菌(PA)是血流感染的第三大常见革兰氏阴性病原体, 这些感染的粗死亡率为39%。尽管其频率和严重性, 与肺炎、烧伤感染和肺炎相比,对PA血流感染的了解相对较少。 角膜炎。为了研究PA血流感染的发病机制,我们使用了小鼠模型,其中 尾静脉注射条形码细菌文库。我们的初步实验 意想不到的发现首先,在大约一半的重症菌血症小鼠中, 散布在整个身体的是几个细菌细胞的后代,这表明只有一小部分细菌细胞, 最初接种物中的PA数量持续存在并传播,导致严重疾病。第二,PA 血液中的细菌通过一个狭窄的瓶颈迁移到胆囊,胆囊是一个保护性的小生境, 允许少量的PA复制到极高的数量。从那里,这些 只有少数PA细菌在肠道内播种,可能是通过胆总管。这 这一发现在其他报告的背景下特别有趣,这些报告表明PA能够从 肠道进入血液总之,这些观察结果提出了一个有趣的假设, 从血液到肠道再回到血液中的PA可能会产生“正反馈”, 胆囊在其中充当PA数字的放大器。在本申请中,我们提出解决 这一限制,并直接测试我们的假设,通过执行以下具体目标:(1)表征 PA血流感染过程中的细菌动力学。(2)确定干预措施是否 干扰PA通过肠道的转运改善血流感染的结果。完成 这些目标有可能揭示导致不良结局的新的致病机制 在PA血流感染中观察到。这些研究的影响有三个方面:(一)它们可以提供一个 研究PA以外的细菌引起的血流感染的发病机制的基本原理;(ii) 获得的知识可以作为基础和理由,进行更昂贵和更艰苦的研究, PA血流感染的人;和(iii)这些研究可能为新的治疗干预提供信息, 降低目前与PA菌血症相关的高死亡率。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Forest and Trees: Exploring Bacterial Virulence with Genome-wide Association Studies and Machine Learning.
  • DOI:
    10.1016/j.tim.2020.12.002
  • 发表时间:
    2021-07
  • 期刊:
  • 影响因子:
    15.9
  • 作者:
    Allen JP;Snitkin E;Pincus NB;Hauser AR
  • 通讯作者:
    Hauser AR
Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital.
美国学术医院铜绿假单胞菌血流感染的氨基糖苷耐药性基因组学。
  • DOI:
    10.1128/spectrum.05087-22
  • 发表时间:
    2023-06-15
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
  • 通讯作者:
Taxonomic characterization of Pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic.
  • DOI:
    10.1128/spectrum.01838-21
  • 发表时间:
    2023-09-22
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Turner, Timothy L.;Mitra, Sumitra D.;Kochan, Travis J.;Pincus, Nathan B.;Lebrun-Corbin, Marine;Cheung, Bettina H.;Gatesy, Samuel W.;Afzal, Tania;Nozick, Sophie H.;Ozer, Egon A.;Hauser, Alan R.
  • 通讯作者:
    Hauser, Alan R.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALAN R HAUSER其他文献

ALAN R HAUSER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALAN R HAUSER', 18)}}的其他基金

Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10641659
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10827545
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10333874
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
Medical Scientist Training Program
医学科学家培训计划
  • 批准号:
    10664364
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
High-Risk Clones of Pseudomonas aeruginosa
铜绿假单胞菌的高风险克隆
  • 批准号:
    10294368
  • 财政年份:
    2021
  • 资助金额:
    $ 19.75万
  • 项目类别:
High-Risk Clones of Pseudomonas aeruginosa
铜绿假单胞菌的高风险克隆
  • 批准号:
    10408175
  • 财政年份:
    2021
  • 资助金额:
    $ 19.75万
  • 项目类别:
Assessing SARS-CoV-2 Variant Evolution in Patients
评估患者中的 SARS-CoV-2 变异进化
  • 批准号:
    10426993
  • 财政年份:
    2021
  • 资助金额:
    $ 19.75万
  • 项目类别:
Dynamics of Pseudomonas aeruginosa During Bacteremia
菌血症期间铜绿假单胞菌的动态
  • 批准号:
    10042352
  • 财政年份:
    2020
  • 资助金额:
    $ 19.75万
  • 项目类别:
Systems Biology Modeling of Severe Hospital-Acquired Pneumonia
严重医院获得性肺炎的系统生物学模型
  • 批准号:
    10551467
  • 财政年份:
    2018
  • 资助金额:
    $ 19.75万
  • 项目类别:
Pathogen and Microbiome Temporal Changes During Resolution of HAP
HAP 消退过程中病原体和微生物组的时间变化
  • 批准号:
    10097985
  • 财政年份:
    2018
  • 资助金额:
    $ 19.75万
  • 项目类别:

相似海外基金

SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
  • 批准号:
    2335504
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Cooperative Agreement
Interferometric and Multiband optical Parametric Amplifiers for Communications (IMPAC)
用于通信的干涉式和多频带光学参量放大器 (IMPAC)
  • 批准号:
    EP/X031918/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Fellowship
Josephson Parametric Amplifiers using CVD graphene junctions
使用 CVD 石墨烯结的约瑟夫森参量放大器
  • 批准号:
    EP/Y003152/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Research Grant
Semiconductor-based Terahertz Traveling Wave Amplifiers for Monolithic Integration
用于单片集成的半导体太赫兹行波放大器
  • 批准号:
    2329940
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Standard Grant
OPTIME-PA: Optimal MMIC Design of E-Band Power Amplifiers for Satcom using Dedicated Measurements and Non-Linear Modelling
OPTIME-PA:使用专用测量和非线性建模的卫星通信 E 频段功率放大器的最佳 MMIC 设计
  • 批准号:
    10075892
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Collaborative R&D
Optical Glass Amplifiers for High Capacity Networks
用于高容量网络的光学玻璃放大器
  • 批准号:
    538379-2018
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Collaborative Research and Development Grants
Investigating the function of ZU5 domain-containing proteins as amplifiers of caspase activation
研究含有 ZU5 结构域的蛋白质作为 caspase 激活放大器的功能
  • 批准号:
    10681326
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
Investigating the function of ZU5 domain-containing proteins as amplifiers of caspase activation
研究含有 ZU5 结构域的蛋白质作为 caspase 激活放大器的功能
  • 批准号:
    10621402
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
Broadband Digital Doherty Amplifiers for Sub-6 GHz 5G wireless Applications
适用于 6 GHz 以下 5G 无线应用的宽带数字 Doherty 放大器
  • 批准号:
    573452-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Alliance Grants
TALENT – Tapered AmpLifiErs for quaNtum Technologies
人才 — 量子技术的锥形放大器
  • 批准号:
    10032436
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了